因美纳与NashBio完成25万全基因组测序 推动药物研发新阶段

DoNews
24 Mar

因美纳公司携手NashBio宣布,“基因组发现联盟(AGD)”项目已成功完成25万个全基因组的测序任务。这一数据库的研究成果正加速药物靶点的发现、治疗研究以及临床开发进程。未来,AGD将引入多组学数据层,进一步拓展数据集的广度、深度和多样性,为精准医疗和药物研发提供更强有力的支持。此举标志着基因组学在医药领域的应用迈入全新阶段。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10